Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science
Neurology April 1st 2026
Psychiatrist.com
From the perspective of the psychiatrist, the best-case scenario is that antidepressant use is merely a marker for dental implant failure. The worst-case scenario is that antidepressant drugs, especially SSRIs, directly predispose to dental implant failure.
Dentistry March 31st 2026
The study authors concluded, “These findings further our understanding of shared and distinct neural mechanisms underlying mood disorders and assist in differential diagnosis, thereby guiding more accurate treatment strategies.”
Psychiatry March 18th 2026
“A fully oral, inexpensive NMDA-AMPA modulation strategy may offer a practical alternative for patients with the bipolar obsessive-compulsive disorder phenotype who respond poorly to conventional approaches.” — Ngo Cheung, MBBS
Conexiant
The authors suggest that an effective, smartphone-delivered CBT program could expand access to first-line treatment for GAD—particularly in settings where traditional therapy is difficult to obtain.
British Medical Journal (The BMJ)
“Selecting a GLP-1 receptor agonist over another antihyperglycemic drug could plausibly confer ancillary benefit” in patients at high risk for or living with an SUD. — Study authors
Endocrinology, Diabetes, Metabolism March 18th 2026